Aptorum Group Limited (APM)
1.10
0.29 (34.97%)
At close: Apr 15, 2025, 3:59 PM
1.08
-1.83%
After-hours: Apr 15, 2025, 05:59 PM EDT
34.97% (1D)
| Bid | 1.08 |
| Market Cap | 7.86M |
| Revenue (ttm) | 1.2M |
| Net Income (ttm) | -10.74M |
| EPS (ttm) | 0.32 |
| PE Ratio (ttm) | 3.44 |
| Forward PE | -1.55 |
| Analyst | n/a |
| Ask | 1.16 |
| Volume | 1,893,051 |
| Avg. Volume (20D) | 86,998 |
| Open | 0.81 |
| Previous Close | 0.81 |
| Day's Range | 0.81 - 1.34 |
| 52-Week Range | 0.46 - 7.88 |
| Beta | -0.38 |
About APM
Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphyloc...
Industry Biotechnology
Sector Healthcare
IPO Date Dec 18, 2018
Employees 3
Stock Exchange NASDAQ
Ticker Symbol APM
Website https://www.aptorumgroup.com
